{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T15:16:05Z","timestamp":1776784565119,"version":"3.51.2"},"reference-count":28,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.pharma.2016.03.007","type":"journal-article","created":{"date-parts":[[2016,5,8]],"date-time":"2016-05-08T04:04:41Z","timestamp":1462680281000},"page":"439-447","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Impact of pharmaceutical intervention on quality of life and coping strategies in patients with haematological malignancies"],"prefix":"10.1016","volume":"74","author":[{"given":"M.-A.","family":"Opsomer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Anota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Noblot-Rossignol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Bonnetain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Pernot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.-L.","family":"Chretien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Legouge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Caillot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Boulin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharma.2016.03.007_bib0145","series-title":"Estimation nationale de l\u2019incidence des cancers en France entre 1980 et 2012. Partie 2 - h\u00e9mopathies malignes. Synth\u00e8se","first-page":"8","author":"Monnereau","year":"2013"},{"key":"10.1016\/j.pharma.2016.03.007_bib0150","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","article-title":"The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology","volume":"85","author":"Aaronson","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.pharma.2016.03.007_bib0155","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1017\/S0033291700002026","article-title":"Development of a questionnaire measure of adjustment to cancer: the MAC scale","volume":"18","author":"Watson","year":"1988","journal-title":"Psychol Med"},{"key":"10.1016\/j.pharma.2016.03.007_bib0160","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1016\/j.ejca.2010.07.023","article-title":"Time until definitive quality of life score deterioration as a means of longitudinal analysis for treatment trials in patients with metastatic pancreatic adenocarcinoma","volume":"46","author":"Bonnetain","year":"2010","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.pharma.2016.03.007_bib0165","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1200\/JCO.1998.16.1.139","article-title":"Interpreting the significance of changes in health-related quality-of-life scores","volume":"16","author":"Osoba","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.pharma.2016.03.007_bib0170","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1002\/(SICI)1097-0258(19971030)16:20<2349::AID-SIM667>3.0.CO;2-E","article-title":"Using the general linear mixed model to analyse unbalanced repeated measures and longitudinal data","volume":"16","author":"Cnaan","year":"1997","journal-title":"Stat Med"},{"key":"10.1016\/j.pharma.2016.03.007_bib0175","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.2146\/ajhp060547","article-title":"Effect of pharmaceutical care on blood pressure control and health-related quality of life in patients with resistant hypertension","volume":"64","author":"De Souza","year":"2007","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.pharma.2016.03.007_bib0180","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s11096-013-9784-x","article-title":"Impact of pharmaceutical care on knowledge, quality of life and satisfaction of postmenopausal women with osteoporosis","volume":"35","author":"Lai","year":"2013","journal-title":"Int J Clin Pharm"},{"key":"10.1016\/j.pharma.2016.03.007_bib0185","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/1745-6215-13-244","article-title":"Impact of pharmaceutical care on the quality of life of patients with Chagas disease and heart failure: randomized clinical trial","volume":"13","author":"Sperandio da Silva","year":"2012","journal-title":"Trials"},{"key":"10.1016\/j.pharma.2016.03.007_bib0190","first-page":"105","article-title":"Coping strategies, quality of life and pain in women with breast cancer","volume":"18","author":"Khalili","year":"2013","journal-title":"Iran J Nurs Midwifery Res"},{"key":"10.1016\/j.pharma.2016.03.007_bib0195","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1002\/pon.3532","article-title":"Communication, coping, and quality of life of breast cancer survivors and family\/friend dyads: a pilot study of Chinese-Americans and Korean-Americans","volume":"23","author":"Lim","year":"2014","journal-title":"Psychooncology"},{"key":"10.1016\/j.pharma.2016.03.007_bib0200","doi-asserted-by":"crossref","first-page":"658","DOI":"10.3349\/ymj.2013.54.3.658","article-title":"Relationship between negative mental adjustment to cancer and distress in thyroid cancer patients","volume":"54","author":"Seok","year":"2013","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.pharma.2016.03.007_bib0205","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1186\/1471-2407-11-283","article-title":"Mental adjustment to cancer and its relation to anxiety, depression, HRQL and survival in patients with laryngeal cancer - a longitudinal study","volume":"11","author":"Johansson","year":"2011","journal-title":"BMC Cancer"},{"key":"10.1016\/j.pharma.2016.03.007_bib0210","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/ejh.12335","article-title":"Impact of therapy and disease related symptoms on health-related quality of life in patients with follicular lymphoma: results of the population-based PHAROS-registry","volume":"93","author":"Oerlemans","year":"2014","journal-title":"Eur J Hematol"},{"key":"10.1016\/j.pharma.2016.03.007_bib0215","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/S1470-2045(09)70258-X","article-title":"Quality of life after successful treatment of early-stage Hodgkin's lymphoma: 10-year follow-up of the EORTC-GELA H8 randomised controlled trial","volume":"10","author":"Heutte","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.pharma.2016.03.007_bib0220","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1080\/10428190500244183","article-title":"Quality of life in chronic lymphocytic leukemia: a neglected issue","volume":"46","author":"Molica","year":"2005","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.pharma.2016.03.007_bib0225","first-page":"222","article-title":"Counselling and adverse event management for patients with myelodysplastic syndromes undergoing azacitidine therapy: a practice standard for Canadian nurses","volume":"22","author":"Murray","year":"2013","journal-title":"Can Oncol Nurs J"},{"key":"10.1016\/j.pharma.2016.03.007_bib0230","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.bbmt.2008.09.023","article-title":"Changes in quality-of-life and psychosocial adjustment among multiple myeloma patients treated with high-dose melphalan and autologous stem cell transplantation","volume":"15","author":"Sherman","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.pharma.2016.03.007_bib0235","series-title":"Newsletter avril - groupe de travail focus sur l\u2019\u00e9ducation th\u00e9rapeutique","author":"Soci\u00e9t\u00e9 fran\u00e7aise de pharmacie clinique","year":"2014"},{"key":"10.1016\/j.pharma.2016.03.007_bib0240","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1111\/pme.12177","article-title":"Sex differences in the medical care of VA patients with chronic non-cancer pain","volume":"14","author":"Weimer","year":"2013","journal-title":"Pain Med"},{"key":"10.1016\/j.pharma.2016.03.007_bib0245","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0277-9536(00)00139-8","article-title":"The impact of marital status on cancer survival","volume":"52","author":"Kravdal","year":"2001","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.pharma.2016.03.007_bib0250","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1634\/theoncologist.12-12-1456","article-title":"Does marital status impact survival and quality of life in patients with non-small cell lung cancer? Observations from the Mayo Clinic lung cancer cohort","volume":"12","author":"Jatoi","year":"2007","journal-title":"Oncologist"},{"key":"10.1016\/j.pharma.2016.03.007_bib0255","first-page":"310","article-title":"Quality of life of patients with breast cancer receiving hormonal therapy, depending on age and marital status","volume":"55","author":"Trishikina","year":"2009","journal-title":"Vopr Onkol"},{"key":"10.1016\/j.pharma.2016.03.007_bib0260","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.paid.2005.05.018","article-title":"Relations between coping responses and optimism-pessimism in predicting anticipatory psychological distress in surgical breast cancer patients","volume":"40","author":"David","year":"2006","journal-title":"Pers Individ Dif"},{"key":"10.1016\/j.pharma.2016.03.007_bib0265","doi-asserted-by":"crossref","first-page":"8884","DOI":"10.1200\/JCO.2005.02.2343","article-title":"Health behaviors of cancer survivors: examining opportunities for cancer control intervention","volume":"23","author":"Bellizzi","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.pharma.2016.03.007_bib0270","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1037\/0022-006X.68.5.875","article-title":"Emotionally expressive coping predicts psychological and physical adjustment to breast cancer","volume":"68","author":"Stanton","year":"2000","journal-title":"J Consult Clin Psychol"},{"key":"10.1016\/j.pharma.2016.03.007_bib0275","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s10865-005-4664-z","article-title":"Coping with prostate cancer: a meta-analytic review","volume":"28","author":"Roesch","year":"2005","journal-title":"J Behav Med"},{"key":"10.1016\/j.pharma.2016.03.007_bib0280","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/pon.928","article-title":"Quality of life of husbands of women with breast cancer","volume":"15","author":"Wagner","year":"2006","journal-title":"Psychooncology"}],"container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450916300050?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450916300050?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T23:31:53Z","timestamp":1757719913000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003450916300050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S0003450916300050"],"URL":"https:\/\/doi.org\/10.1016\/j.pharma.2016.03.007","relation":{},"ISSN":["0003-4509"],"issn-type":[{"value":"0003-4509","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of pharmaceutical intervention on quality of life and coping strategies in patients with haematological malignancies","name":"articletitle","label":"Article Title"},{"value":"Annales Pharmaceutiques Fran\u00e7aises","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharma.2016.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Acad\u00e9mie Nationale de Pharmacie. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}